Surgery Partners (SGRY) Competitors $21.01 -1.21 (-5.45%) Closing price 07/24/2025 04:00 PM EasternExtended Trading$21.28 +0.27 (+1.31%) As of 07/24/2025 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGRY vs. GH, OPCH, RDNT, BTSG, SHC, CON, PRVA, WGS, VCYT, and ARDTShould you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry. Surgery Partners vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Ardent Health Surgery Partners (NASDAQ:SGRY) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Do analysts rate SGRY or GH? Surgery Partners presently has a consensus price target of $33.56, suggesting a potential upside of 59.71%. Guardant Health has a consensus price target of $54.45, suggesting a potential upside of 19.70%. Given Surgery Partners' higher probable upside, equities analysts plainly believe Surgery Partners is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surgery Partners 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Guardant Health 0 Sell rating(s) 0 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 3.05 Do insiders & institutionals have more ownership in SGRY or GH? 92.6% of Guardant Health shares are owned by institutional investors. 2.3% of Surgery Partners shares are owned by insiders. Comparatively, 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, SGRY or GH? Surgery Partners has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500. Does the media favor SGRY or GH? In the previous week, Guardant Health had 11 more articles in the media than Surgery Partners. MarketBeat recorded 17 mentions for Guardant Health and 6 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.99 beat Guardant Health's score of 0.48 indicating that Surgery Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Surgery Partners 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Is SGRY or GH more profitable? Surgery Partners has a net margin of -6.10% compared to Guardant Health's net margin of -53.82%. Surgery Partners' return on equity of 2.41% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Surgery Partners-6.10% 2.41% 0.99% Guardant Health -53.82%N/A -26.77% Which has preferable earnings & valuation, SGRY or GH? Surgery Partners has higher revenue and earnings than Guardant Health. Surgery Partners is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurgery Partners$3.17B0.85-$168.10M-$1.53-13.73Guardant Health$739.02M7.63-$436.37M-$3.39-13.42 SummarySurgery Partners beats Guardant Health on 9 of the 17 factors compared between the two stocks. Get Surgery Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGRY vs. The Competition Export to ExcelMetricSurgery PartnersMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.85B$7.20B$5.73B$9.47BDividend YieldN/A2.81%4.60%3.99%P/E Ratio-13.7325.2027.9819.95Price / Sales0.8540.90451.34100.89Price / Cash11.8628.2736.5558.97Price / Book0.849.698.645.90Net Income-$168.10M$239.98M$3.24B$258.42M7 Day Performance-5.87%2.63%3.69%2.11%1 Month Performance-3.22%5.86%10.34%12.44%1 Year Performance-31.67%17.31%34.32%19.55% Surgery Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGRYSurgery Partners3.0928 of 5 stars$21.01-5.4%$33.56+59.7%-29.2%$2.85B$3.17B-13.7315,000GHGuardant Health4.4586 of 5 stars$49.77-1.0%$53.76+8.0%+43.1%$6.17B$739.02M-14.682,021Upcoming EarningsAnalyst RevisionOPCHOption Care Health4.5947 of 5 stars$30.68+2.7%$35.50+15.7%-4.9%$5.02B$5.00B24.748,088Positive NewsUpcoming EarningsRDNTRadNet3.6755 of 5 stars$56.59+2.0%$69.60+23.0%-12.0%$4.25B$1.87B-131.6011,021News CoveragePositive NewsBTSGBrightSpring Health Services1.9537 of 5 stars$20.31flat$24.90+22.6%+71.6%$3.57B$11.86B72.5435,000Upcoming EarningsSHCSotera Health3.2843 of 5 stars$11.61-1.6%$16.00+37.8%-9.5%$3.30B$1.10B145.143,000News CoveragePositive NewsCONConcentra Group Holdings Parent3.1717 of 5 stars$20.23+1.6%$28.50+40.9%N/A$2.59B$1.90B15.0911,250PRVAPrivia Health Group4.1072 of 5 stars$20.89+2.1%$28.38+35.9%+0.3%$2.55B$1.80B174.101,140Positive NewsWGSGeneDx4.0815 of 5 stars$82.39-0.2%$92.33+12.1%+140.7%$2.35B$330.14M-58.431,200Upcoming EarningsVCYTVeracyte3.8086 of 5 stars$26.65-1.6%$40.90+53.5%+0.7%$2.09B$445.76M65.00790Positive NewsARDTArdent Health3.7119 of 5 stars$14.51+2.4%$20.67+42.4%-35.5%$2.08B$5.97B8.9024,900 Related Companies and Tools Related Companies Guardant Health Competitors Option Care Health Competitors RadNet Competitors BrightSpring Health Services Competitors Sotera Health Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors GeneDx Competitors Veracyte Competitors Ardent Health Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGRY) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surgery Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.